Intratumoral Delivery of Plasmid IL12 Via Electroporation Leads to Regression of Injected and Noninjected Tumors in Merkel Cell Carcinoma von Bhatia, Shailender, Longino, Natalie V., Miller, Natalie J., Kulikauskas, Rima, Iyer, Jayasri G., Ibrani, Dafina, Blom, Astrid, Byrd, David R., Parvathaneni, Upendra, Twitty, Christopher G., Campbell, Jean S., Le, Mai H., Gargosky, Sharron, Pierce, Robert H., Heller, Richard, Daud, Adil I., Nghiem, Paul

Volltext

Tumor-Derived Autophagosome Vaccine: Induction of Cross-Protective Immune Responses against Short-lived Proteins through a p62-Dependent Mechanism von TWITTY, Christopher G, JENSEN, Shawn M, HU, Hong-Ming, FOX, Bernard A

Volltext

Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12 von Garris, Christopher S., Arlauckas, Sean P., Kohler, Rainer H., Trefny, Marcel P., Garren, Seth, Piot, Cécile, Engblom, Camilla, Pfirschke, Christina, Siwicki, Marie, Gungabeesoon, Jeremy, Freeman, Gordon J., Warren, Sarah E., Ong, SuFey, Browning, Erica, Twitty, Christopher G., Pierce, Robert H., Le, Mai H., Algazi, Alain P., Daud, Adil I., Pai, Sara I., Zippelius, Alfred, Weissleder, Ralph, Pittet, Mikael J.

Volltext

Amplification of the CXCR3/CXCL9 axis via intratumoral electroporation of plasmid CXCL9 synergizes with plasmid IL-12 therapy to elicit robust anti-tumor immunity von Lee, Jack Y., Nguyen, Bianca, Mukhopadhyay, Anandaroop, Han, Mia, Zhang, Jun, Gujar, Ravindra, Salazar, Jon, Hermiz, Reneta, Svenson, Lauren, Browning, Erica, Lyerly, H. Kim, Canton, David A., Fisher, Daniel, Daud, Adil, Algazi, Alain, Skitzki, Joseph, Twitty, Christopher G.

Volltext

Phase II Trial of IL-12 Plasmid Transfection and PD-1 Blockade in Immunologically Quiescent Melanoma von Algazi, Alain P., Twitty, Christopher G., Tsai, Katy K., Le, Mai, Pierce, Robert, Browning, Erica, Hermiz, Reneta, Canton, David A., Bannavong, Donna, Oglesby, Arielle, Francisco, Murray, Fong, Lawrence, Pittet, Mikael J., Arlauckas, Sean P., Garris, Christopher, Levine, Lauren P., Bifulco, Carlos, Ballesteros-Merino, Carmen, Bhatia, Shailender, Gargosky, Sharron, Andtbacka, Robert H. I., Fox, Bernard A., Rosenblum, Michael D., Daud, Adil I.

Volltext

Retroviral Replicating Vector Delivery of miR-PDL1 Inhibits Immune Checkpoint PDL1 and Enhances Immune Responses In Vitro von Lin, Amy H., Twitty, Christopher G., Burnett, Ryan, Hofacre, Andrew, Mitchell, Leah A., Espinoza, Fernando Lopez, Gruber, Harry E., Jolly, Douglas J.

Volltext

Intratumoral Plasmid IL12 Expands CD8(+) T Cells and Induces a CXCR3 Gene Signature in Triple-negative Breast Tumors that Sensitizes Patients to Anti-PD-1 Therapy von Telli, Melinda L., Nagata, Hiroshi, Wapnir, Irene, Acharya, Chaitanya R., Zablotsky, Kaitlin, Fox, Bernard A., Bifulco, Carlo B., Jensen, Shawn M., Ballesteros-Merino, Carmen, Le, Mai Hope, Pierce, Robert H., Browning, Erica, Hermiz, Reneta, Svenson, Lauren, Bannavong, Donna, Jaffe, Kim, Sell, Jendy, Foerter, Kellie Malloy, Canton, David A., Twitty, Christopher G., Osada, Takuya, Lyerly, H. Kim, Crosby, Erika J.

Volltext

Intratumoral Plasmid IL12 Electroporation Therapy in Patients with Advanced Melanoma Induces Systemic and Intratumoral T-cell Responses von Greaney, Samantha K., Algazi, Alain P., Tsai, Katy K., Takamura, Kathryn T., Chen, Lawrence, Twitty, Christopher G., Zhang, Li, Paciorek, Alan, Pierce, Robert H., Le, Mai H., Daud, Adil, Fong, Lawrence

Volltext

Prognostic Biomarkers for Melanoma Immunotherapy von Twitty, Christopher G., Huppert, Laura A., Daud, Adil I.

Volltext

Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12 von Garris, Christopher S., Arlauckas, Sean P., Kohler, Rainer H., Trefny, Marcel P., Garren, Seth, Piot, Cécile, Engblom, Camilla, Pfirschke, Christina, Siwicki, Marie, Gungabeesoon, Jeremy, Freeman, Gordon J., Warren, Sarah E., Ong, SuFey, Browning, Erica, Twitty, Christopher G., Pierce, Robert H., Le, Mai H., Algazi, Alain P., Daud, Adil I., Pai, Sara I., Zippelius, Alfred, Weissleder, Ralph, Pittet, Mikael J.

Volltext

Intratumoral Electroporation of Plasmid Encoded IL12 and Membrane-Anchored Anti-CD3 Increases Systemic Tumor Immunity von Han, Mia, Nguyen, Bianca, Lee, Jack Y, Browning, Erica, Zhang, Jun, Mukhopadhyay, Anandaroop, Gujar, Ravindra, Salazar, Jon, Hermiz, Reneta, Svenson, Lauren, Rolig, Annah S, Redmond, William L, Algazi, Alain P, Daud, Adil I, Canton, David A, Twitty, Christopher G

Volltext

Increased frequency of suppressive regulatory T cells and T cell-mediated antigen loss results in murine melanoma recurrence von Jensen, Shawn M, Twitty, Christopher G, Maston, Levi D, Antony, Paul A, Lim, May, Hu, Hong-Ming, Petrausch, Ulf, Restifo, Nicholas P, Fox, Bernard A

Volltext

Multiple vaccinations: friend or foe von Church, Sarah E, Jensen, Shawn M, Twitty, Christopher G, Bahjat, Keith, Hu, Hong-Ming, Urba, Walter J, Fox, Bernard A

Volltext

Evaluation of the long-term anti-Spike immune response following a novel coronavirus vaccine (CORVax): electroporation of SARS-CoV-2 Spike plasmid DNA plus IL12 plasmid DNA von Jensen, Shawn M, Afentoulis, Michael, Wegmann, Keith, Canton, David A, Twitty, Christopher G, Fox, Bernard A

Volltext

Abstract 3195: Intratumoral electroporation of plasmid IL-12 and CXCL9 with membrane-bound anti-CD3 elicits robust anti-tumor immunity von Han, Mia, Mukhopadhyay, Anandaroop, Nguyen, Bianca, Sakurada, Kurt, Lee, Jack, Canton, David A., Twitty, Christopher G.

Volltext

Abstract CT022: Intratumoral plasmid IL-12 and electroporation in pre-treated inoperable locally advanced or recurrent triple-negative breast cancer (TNBC) von Telli, Melinda L., Zablotsky, Kaitlin, Gargosky, Sharron E., Twitty, Christopher G., Wapnir, Irene L.

Volltext

Abstract P2-14-06: Durable responses with intratumoral electroporation of plasmid interleukin-12 plus pembrolizumab in patients with advanced triple-negative breast cancer: Cohort... von Telli, Melinda L., Wapnir, Irene, Devitt, Bianca, Cuff, Katharine, Soliman, Hatem, Vinayak, Shaveta, Canton, David A., Twitty, Christopher G., Xie, Sunny, Lu, Ying, Bannavong, Donna, O'Keeffe, Bridget, Aung, Sandra, Joshi, Rohit

Volltext

Abstract LB-396: Amplification of the CXCR3/CXCL9 axis via intratumoral electroporation of CXCL9 synergizes with IL-12 gene therapy (TAVO) to elicit robust anti-tumor immunity von Mukhopadhyay, Anandaroop, Nguyen, Bianca, Lee, Jack Y., Han, Mia, Salazar, Jon, Hermiz, Reneta, Svenson, Lauren, Browning, Erica, O'Connor, Daniel J., Canton, David A., Fisher, Daniel, Skitzki, Joseph, Twitty, Christopher G.

Volltext

Abstract LB-390: Intratumoral electroporation of plasmid-encoded IL-12 and membrane-bound anti-CD3 increases tumor immunogenicity and augments the function of T cell subsets von Han, Mia, Mukhopadhyay, Anandaroop, Nguyen, Bianca, Lee, Jack Y., Browning, Erica, Salazar, Jon, Hermiz, Reneta, Svenson, Lauren, Baker, Chris, O'Connor, Daniel, Malloy, Kellie, Canton, David A., Twitty, Christopher G.

Volltext

Abstract P006: Intratumoral electroporation of IL-12 and SARS-Cov-2 spike plasmids drives a coordinated vaccine response and elicits robust anti-tumor immunity von Han, Mia, Lee, Jack Y., Wu, Vincent, Sakurada, Kurt, Nguyen, Bianca, Canton, David A., Twitty, Christopher G.

Volltext